{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T18:58:44Z","timestamp":1760295524366},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,12]],"date-time":"2008-02-12T00:00:00Z","timestamp":1202774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Early relapse in colorectal cancer (CRC) patients is attributed mainly to the higher malignant entity (such as an unfavorable genotype, deeper tumor invasion, lymph node metastasis and advance cancer stage) and poor response to chemotherapy. Several investigations have demonstrated that genetic polymorphisms in drug-targeted genes, metabolizing enzymes, and DNA-repairing enzymes are all strongly correlated with inter-individual differences in the efficacy and toxicity of many treatment regimens. This preliminary study attempts to identify the correlation between genetic polymorphisms and clinicopathological features of CRC, and evaluates the relationship between genetic polymorphisms and chemotherapeutic susceptibility of Taiwanese CRC patients. To our knowledge, this study discusses, for the first time, early cancer relapse and its indication by multiple genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Six gene polymorphisms functional in drug-metabolism \u2013 <jats:italic>GSTP1<\/jats:italic> Ile105Val, <jats:italic>ABCB1<\/jats:italic> Ile1145Ile, <jats:italic>MTHFR<\/jats:italic> Ala222Val, <jats:italic>TYMS<\/jats:italic> double (2R) or triple (3R) tandem repeat \u2013 and DNA-repair genes \u2013 <jats:italic>ERCC2<\/jats:italic> Lys751Gln and <jats:italic>XRCC1 A<\/jats:italic>rg399Gln \u2013 were assessed in 201 CRC patients using a polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP) technique and DNA sequencing. Patients were diagnosed as either high-risk stage II (T2 and 3 N0 M0) or III (any T N1 and 2 M0) and were administered adjuvant chemotherapy regimens that included 5-fluorouracil (5FU) and leucovorin (LV). The correlations between genetic polymorphisms and patient clinicopathological features and relapses were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In this study, the distributions of <jats:italic>GSTP1<\/jats:italic> (<jats:italic>P<\/jats:italic> = 0.003), <jats:italic>ABCB1<\/jats:italic> (<jats:italic>P<\/jats:italic> = 0.001), <jats:italic>TYMS<\/jats:italic> (<jats:italic>P<\/jats:italic> &lt; 0.0001), <jats:italic>ERCC2<\/jats:italic> (<jats:italic>P<\/jats:italic> &lt; 0.0001) and <jats:italic>XRCC1<\/jats:italic> (<jats:italic>P<\/jats:italic> = 0.006) genotypes in the Asian population, with the exception of <jats:italic>MTHFR<\/jats:italic> (<jats:italic>P<\/jats:italic> = 0.081), differed significantly from their distributions in a Caucasian population. However, the unfavorable genotype <jats:italic>ERCC2<\/jats:italic> 2251A&gt;C (<jats:italic>P<\/jats:italic> = 0.006), tumor invasion depth (<jats:italic>P<\/jats:italic> = 0.025), lymph node metastasis (<jats:italic>P<\/jats:italic> = 0.011) and cancer stage (<jats:italic>P<\/jats:italic> = 0.008) were significantly correlated with early relapse. Patients carrying the <jats:italic>ERCC2<\/jats:italic> 2251AC or2251CC genotypes had a significantly increased risk of early relapse (OR = 3.294, 95% CI, 1.272\u20138.532).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We suggest that <jats:italic>ERCC2<\/jats:italic> 2251A&gt;C alleles may be genetic predictors of early CRC relapse.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-8-50","type":"journal-article","created":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T19:13:59Z","timestamp":1204658039000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["ERCC22251A&gt;C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study"],"prefix":"10.1186","volume":"8","author":[{"given":"Ming-Yii","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiu-Ru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,12]]},"reference":[{"issue":"3","key":"988_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3816\/CCC.2004.n.020","volume":"4","author":"LT Chen","year":"2004","unstructured":"Chen LT, Whang-Peng J: Current status of clinical studies for colorectal cancer in Taiwan. Clinical colorectal cancer. 2004, 4 (3): 196-203.","journal-title":"Clinical colorectal cancer"},{"issue":"5","key":"988_CR2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/030089160609200504","volume":"92","author":"A Bonetti","year":"2006","unstructured":"Bonetti A, Zaninelli M, Durante E, Fraccon AP, Franceschi T, Pasini F, Zustovich F, Brienza S: Multiple-target chemotherapy (LV-modulated 5-FU bolus and continuous infusion, oxaliplatin, CPT-11) in advanced 5-FU-refractory colorectal cancer: MTD definition and efficacy evaluation. A phase I\u2013II study. Tumori. 2006, 92 (5): 389-395.","journal-title":"Tumori"},{"issue":"Suppl 5","key":"988_CR3","doi-asserted-by":"publisher","first-page":"v128","DOI":"10.1093\/annonc\/mdg756","volume":"14","author":"MP Coleman","year":"2003","unstructured":"Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F: EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003, 14 (Suppl 5): v128-149. 10.1093\/annonc\/mdg756.","journal-title":"Ann Oncol"},{"issue":"8","key":"988_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00384-007-0293-z","volume":"22","author":"JH Ju","year":"2007","unstructured":"Ju JH, Chang SC, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC, Hung H, Wang FM, Lin JK: Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis. 2007, 22 (8): 855-862. 10.1007\/s00384-007-0293-z.","journal-title":"Int J Colorectal Dis"},{"issue":"6 Suppl 8","key":"988_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.seminoncol.2005.06.004","volume":"32","author":"A Gramont","year":"2005","unstructured":"Gramont A: Adjuvant therapy of stage II and III colon cancer. Semin Oncol. 2005, 32 (6 Suppl 8): 11-14. 10.1053\/j.seminoncol.2005.06.004.","journal-title":"Semin Oncol"},{"issue":"8","key":"988_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/sj.bjc.6604011","volume":"97","author":"W Schippinger","year":"2007","unstructured":"Schippinger W, Samonigg H, Schaberl-Moser R, Greil R, Thodtmann R, Tschmelitsch J, Jagoditsch M, Steger GG, Jakesz R, Herbst F, Hofbauer F, Rabl H, Wohlmuth P, Gnant M, Thaler J: A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Br J Cancer. 2007, 97 (8): 1021-1027. 10.1038\/sj.bjc.6604011.","journal-title":"Br J Cancer"},{"issue":"19","key":"988_CR7","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1074\/jbc.274.19.13176","volume":"274","author":"F Gebhardt","year":"1999","unstructured":"Gebhardt F, Zanker KS, Brandt B: Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem. 1999, 274 (19): 13176-13180. 10.1074\/jbc.274.19.13176.","journal-title":"J Biol Chem"},{"issue":"6","key":"988_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/10715769900301121","volume":"31","author":"S Goto","year":"1999","unstructured":"Goto S, Iida T, Cho S, Oka M, Kohno S, Kondo T: Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res. 1999, 31 (6): 549-558. 10.1080\/10715769900301121.","journal-title":"Free Radic Res"},{"issue":"24","key":"988_CR9","first-page":"6921","volume":"60","author":"Y Ando","year":"2000","unstructured":"Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y: Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res. 2000, 60 (24): 6921-6926.","journal-title":"Cancer Res"},{"issue":"24","key":"988_CR10","first-page":"8654","volume":"61","author":"DJ Park","year":"2001","unstructured":"Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ: A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res. 2001, 61 (24): 8654-8658.","journal-title":"Cancer Res"},{"issue":"1","key":"988_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/sj.tpj.6500012","volume":"1","author":"ST Pullarkat","year":"2001","unstructured":"Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, Warren R, Tsao-Wei D, Groshen S, Lenz HJ: Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. 2001, 1 (1): 65-70.","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"988_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/jnci\/djh015","volume":"96","author":"KJ Sohn","year":"2004","unstructured":"Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI: Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst. 2004, 96 (2): 134-144.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"988_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1245\/s10434-006-9112-y","volume":"13","author":"KW Suh","year":"2006","unstructured":"Suh KW, Kim JH, Kim do Y, Kim YB, Lee C, Choi S: Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?. Ann Surg Oncol. 2006, 13 (11): 1379-1385. 10.1245\/s10434-006-9112-y.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"988_CR14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1200\/JCO.2006.08.1844","volume":"25","author":"A Ruzzo","year":"2007","unstructured":"Ruzzo A, Graziano F, Loupakis F, Rulli E, Canestrari E, Santini D, Catalano V, Ficarelli R, Maltese P, Bisonni R, Masi G, Schiavon G, Giordani P, Giustini L, Falcone A, Tonini G, Silva R, Mattioli R, Floriani I, Magnani M: Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy. J Clin Oncol. 2007, 25 (10): 1247-1254. 10.1200\/JCO.2006.08.1844.","journal-title":"J Clin Oncol"},{"issue":"3","key":"988_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00001813-199106000-00003","volume":"2","author":"GH Blijham","year":"1991","unstructured":"Blijham GH: Chemotherapy of colorectal cancer. Anticancer Drugs. 1991, 2 (3): 233-245. 10.1097\/00001813-199106000-00003.","journal-title":"Anticancer Drugs"},{"issue":"7","key":"988_CR16","first-page":"1407","volume":"55","author":"PG Johnston","year":"1995","unstructured":"Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res. 1995, 55 (7): 1407-1412.","journal-title":"Cancer Res"},{"issue":"7\u20138","key":"988_CR17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/0959-8049(95)00326-E","volume":"31A","author":"L Leichman","year":"1995","unstructured":"Leichman L, Lenz HJ, Leichman CG, Groshen S, Danenberg K, Baranda J, Spears CP, Boswell W, Silberman H, Ortega A, Stain S, Beart R, Danenberg P: Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur J Cancer. 1995, 31A (7\u20138): 1306-1310. 10.1016\/0959-8049(95)00326-E.","journal-title":"Eur J Cancer"},{"issue":"1","key":"988_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/ctrv.2002.0253","volume":"28","author":"C Aschele","year":"2002","unstructured":"Aschele C, Lonardi S, Monfardini S: Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. Cancer Treat Rev. 2002, 28 (1): 27-47. 10.1053\/ctrv.2002.0253.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"988_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3816\/CCC.2001.n.018","volume":"1","author":"S Marsh","year":"2001","unstructured":"Marsh S, McLeod HL: Thymidylate synthase pharmacogenetics in colorectal cancer. Clinical colorectal cancer. 2001, 1 (3): 175-178. discussion 179\u2013181.","journal-title":"Clinical colorectal cancer"},{"issue":"4","key":"988_CR20","first-page":"604","volume":"58","author":"MR Shen","year":"1998","unstructured":"Shen MR, Jones IM, Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998, 58 (4): 604-608.","journal-title":"Cancer Res"},{"issue":"7","key":"988_CR21","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA. 2000, 97 (7): 3473-3478. 10.1073\/pnas.050585397.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"988_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnci\/94.12.936","volume":"94","author":"J Stoehlmacher","year":"2002","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ: Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2002, 94 (12): 936-942.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"988_CR23","first-page":"4096","volume":"7","author":"K Kawakami","year":"2001","unstructured":"Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, Omura K, Watanabe G, Danenberg PV: Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res. 2001, 7 (12): 4096-4101.","journal-title":"Clin Cancer Res"},{"key":"988_CR24","unstructured":"International Union Against Cancer. TNM classification of malignant tumors. 2002, New York: Wiley-Liss, Inc, 6"},{"key":"988_CR25","unstructured":"Website title. [http:\/\/web.umassmed.edu\/bioapps\/primer3_www.cgi]"},{"issue":"12","key":"988_CR26","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/carcin\/bgh251","volume":"25","author":"EM van der Logt","year":"2004","unstructured":"van der Logt EM, Bergevoet SM, Roelofs HM, van Hooijdonk Z, te Morsche RH, Wobbes T, de Kok JB, Nagengast FM, Peters WH: Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis. 2004, 25 (12): 2407-2415. 10.1093\/carcin\/bgh251.","journal-title":"Carcinogenesis"},{"issue":"10","key":"988_CR27","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3748\/wjg.v11.i10.1473","volume":"11","author":"CC Yeh","year":"2005","unstructured":"Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC: Vegetable\/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol. 2005, 11 (10): 1473-1480.","journal-title":"World J Gastroenterol"},{"issue":"5\u20136","key":"988_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00228-005-0926-5","volume":"61","author":"M Kurzawski","year":"2005","unstructured":"Kurzawski M, Drozdzik M, Suchy J, Kurzawski G, Bialecka M, Gornik W, Lubinski J: Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol. 2005, 61 (5\u20136): 389-394. 10.1007\/s00228-005-0926-5.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"988_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2133\/dmpk.21.126","volume":"21","author":"C Komoto","year":"2006","unstructured":"Komoto C, Nakamura T, Sakaeda T, Kroetz DL, Yamada T, Omatsu H, Koyama T, Okamura N, Miki I, Tamura T, Aoyama N, Kasuga M, Okumura K: MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab Pharmacokinet. 2006, 21 (2): 126-132. 10.2133\/dmpk.21.126.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"8","key":"988_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1349-7006.2006.00241.x","volume":"97","author":"SY Bae","year":"2006","unstructured":"Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK, Shin DW, Pie JE, Woo ZH, Kang JH: Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci. 2006, 97 (8): 774-779. 10.1111\/j.1349-7006.2006.00241.x.","journal-title":"Cancer Sci"},{"issue":"2","key":"988_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1158\/1055-9965.EPI-03-0083","volume":"13","author":"K Curtin","year":"2004","unstructured":"Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM: MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2004, 13 (2): 285-292. 10.1158\/1055-9965.EPI-03-0083.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"988_CR32","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1349-7006.2004.tb02201.x","volume":"95","author":"G Yin","year":"2004","unstructured":"Yin G, Kono S, Toyomura K, Hagiwara T, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Imaizumi N: Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2004, 95 (11): 908-913. 10.1111\/j.1349-7006.2004.tb02201.x.","journal-title":"Cancer Sci"},{"issue":"2","key":"988_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2004.08.014","volume":"216","author":"DH Kim","year":"2004","unstructured":"Kim DH, Ahn YO, Lee BH, Tsuji E, Kiyohara C, Kono S: Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett. 2004, 216 (2): 199-205. 10.1016\/j.canlet.2004.08.014.","journal-title":"Cancer Lett"},{"issue":"18","key":"988_CR34","first-page":"6004","volume":"63","author":"K Kawakami","year":"2003","unstructured":"Kawakami K, Watanabe G: Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res. 2003, 63 (18): 6004-6007.","journal-title":"Cancer Res"},{"issue":"3","key":"988_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/geno.1999.5833","volume":"58","author":"S Marsh","year":"1999","unstructured":"Marsh S, Collie-Duguid ES, Li T, Liu X, McLeod HL: Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics. 1999, 58 (3): 310-312. 10.1006\/geno.1999.5833.","journal-title":"Genomics"},{"issue":"10","key":"988_CR36","first-page":"958","volume":"12","author":"J Chen","year":"2003","unstructured":"Chen J, Hunter DJ, Stampfer MJ, Kyte C, Chan W, Wetmur JG, Mosig R, Selhub J, Ma J: Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2003, 12 (10): 958-962.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"988_CR37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","volume":"91","author":"J Stoehlmacher","year":"2004","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ: A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer. 2004, 91 (2): 344-354.","journal-title":"Br J Cancer"},{"key":"988_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2407-5-12","volume":"5","author":"CC Yeh","year":"2005","unstructured":"Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL: Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer. 2005, 5: 12-10.1186\/1471-2407-5-12.","journal-title":"BMC Cancer"},{"issue":"3","key":"988_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ijc.21019","volume":"116","author":"YC Hong","year":"2005","unstructured":"Hong YC, Lee KH, Kim WC, Choi SK, Woo ZH, Shin SK, Kim H: Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer. 2005, 116 (3): 428-432. 10.1002\/ijc.21019.","journal-title":"Int J Cancer"},{"issue":"11","key":"988_CR40","first-page":"2557","volume":"59","author":"RM Lunn","year":"1999","unstructured":"Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA: XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999, 59 (11): 2557-2561.","journal-title":"Cancer Res"},{"issue":"4","key":"988_CR41","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ijc.1228","volume":"92","author":"G Matullo","year":"2001","unstructured":"Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, Piazza A, Vineis P: DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer. 2001, 92 (4): 562-567. 10.1002\/ijc.1228.","journal-title":"Int J Cancer"},{"issue":"4","key":"988_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/carcin\/23.4.599","volume":"23","author":"SM Hou","year":"2002","unstructured":"Hou SM, Falt S, Angelini S, Yang K, Nyberg F, Lambert B, Hemminki K: The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis. 2002, 23 (4): 599-603. 10.1093\/carcin\/23.4.599.","journal-title":"Carcinogenesis"},{"issue":"1","key":"988_CR43","first-page":"33","volume":"18","author":"R Ankathil","year":"1999","unstructured":"Ankathil R, Jyothish B, Madhavan J, Nair MK: Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer. J Exp Clin Cancer Res. 1999, 18 (1): 33-37.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2 Suppl 5","key":"988_CR44","first-page":"4","volume":"25","author":"E Raymond","year":"1998","unstructured":"Raymond E, Faivre S, Woynarowski JM, Chaney SG: Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol. 1998, 25 (2 Suppl 5): 4-12.","journal-title":"Semin Oncol"},{"issue":"17","key":"988_CR45","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1200\/JCO.2004.05.017","volume":"22","author":"K Shirao","year":"2004","unstructured":"Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL: Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil\/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT\/LV. J Clin Oncol. 2004, 22 (17): 3466-3474. 10.1200\/JCO.2004.05.017.","journal-title":"J Clin Oncol"},{"issue":"7","key":"988_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2174\/1566524033479456","volume":"3","author":"GS Charames","year":"2003","unstructured":"Charames GS, Bapat B: Genomic instability and cancer. Curr Mol Med. 2003, 3 (7): 589-596. 10.2174\/1566524033479456.","journal-title":"Curr Mol Med"},{"issue":"12","key":"988_CR47","first-page":"1513","volume":"11","author":"EL Goode","year":"2002","unstructured":"Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002, 11 (12): 1513-1530.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"988_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","volume":"17","author":"S Benhamou","year":"2002","unstructured":"Benhamou S, Sarasin A: ERCC2\/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002, 17 (6): 463-469. 10.1093\/mutage\/17.6.463.","journal-title":"Mutagenesis"},{"issue":"1","key":"988_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/aje\/kwi018","volume":"161","author":"S Benhamou","year":"2005","unstructured":"Benhamou S, Sarasin A: ERCC2\/XPD gene polymorphisms and lung cancer: a HuGE review. American journal of epidemiology. 2005, 161 (1): 1-14. 10.1093\/aje\/kwi018.","journal-title":"American journal of epidemiology"},{"issue":"4","key":"988_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/aje\/kwj189","volume":"164","author":"M Manuguerra","year":"2006","unstructured":"Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G: XRCC3 and XPD\/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. American journal of epidemiology. 2006, 164 (4): 297-302. 10.1093\/aje\/kwj189.","journal-title":"American journal of epidemiology"},{"issue":"11 Pt 1","key":"988_CR51","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1158\/1055-9965.EPI-05-0270","volume":"14","author":"J Bigler","year":"2005","unstructured":"Bigler J, Ulrich CM, Kawashima T, Whitton J, Potter JD: DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps. Cancer Epidemiol Biomarkers Prev. 2005, 14 (11 Pt 1): 2501-2508. 10.1158\/1055-9965.EPI-05-0270.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"988_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cancergencyto.2007.01.010","volume":"175","author":"J Yin","year":"2007","unstructured":"Yin J, Vogel U, Ma Y, Qi R, Sun Z, Wang H: A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2\/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population. Cancer genetics and cytogenetics. 2007, 175 (1): 47-51. 10.1016\/j.cancergencyto.2007.01.010.","journal-title":"Cancer genetics and cytogenetics"},{"issue":"12","key":"988_CR53","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/carcin\/21.12.2219","volume":"21","author":"EM Sturgis","year":"2000","unstructured":"Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, Strom SS, Spitz MR, Wei Q: XPD\/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 2000, 21 (12): 2219-2223. 10.1093\/carcin\/21.12.2219.","journal-title":"Carcinogenesis"},{"issue":"2","key":"988_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/carcin\/23.2.295","volume":"23","author":"Y Qiao","year":"2002","unstructured":"Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M, Grossman L, Mohrenweiser H, Wei Q: Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD\/ERCC2 genotypes. Carcinogenesis. 2002, 23 (2): 295-299. 10.1093\/carcin\/23.2.295.","journal-title":"Carcinogenesis"},{"issue":"9","key":"988_CR55","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/carcin\/22.9.1437","volume":"22","author":"G Matullo","year":"2001","unstructured":"Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E, Krogh V, Munnia A, Tumino R, Polidoro S, Piazza A, Vineis P: XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001, 22 (9): 1437-1445. 10.1093\/carcin\/22.9.1437.","journal-title":"Carcinogenesis"},{"issue":"7","key":"988_CR56","first-page":"674","volume":"12","author":"G Matullo","year":"2003","unstructured":"Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, Masala G, Berrino F, Panico S, Tumino R, Vineis P, Palli D: Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev. 2003, 12 (7): 674-677.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"988_CR57","first-page":"1354","volume":"61","author":"MR Spitz","year":"2001","unstructured":"Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q: Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001, 61 (4): 1354-1357.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"988_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0027-5107(02)00219-1","volume":"509","author":"Y Qiao","year":"2002","unstructured":"Qiao Y, Spitz MR, Guo Z, Hadeyati M, Grossman L, Kraemer KH, Wei Q: Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutation research. 2002, 509 (1\u20132): 165-174.","journal-title":"Mutation research"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-50\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T10:31:45Z","timestamp":1630492305000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-50","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,12]]},"assertion":[{"value":"14 September 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}